ZIOP-XON Fundamental & Technical Discussion Board - Laidlaw Report out this Morning - ZIOP-XON Fundamental & Technical Discussion Board - InvestorVillage
ZIOP-XON Fundamental & Technical Discussion Board
This is a semi-private group. You are free to browse messages, but you must be a member of this group to post messages. Join This Group

Group: ZIOP-XON Fundamental & Technical Discussion Board   /  Message Board  /  Read Message

 
 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  11430 of 14256  at  6/12/2019 3:23:59 PM  by

Digdeeper1976


 In response to msg 11418 by  dogged58
view thread

Re: Laidlaw Report out this Morning

Action. We are reiterating our Buy rating and our target price of $7.50 to reflect our bullish view on the two clinical products advancing and the potential upside from CAR-T development in China. Our valuation is based on probability adjusted DCF, peer comparable, and sum-of-the-parts analyses.

I would love to see the DCF sheet. Is the assumption 1% penetration to the 150 Billion cancer market? Is the TCR trials probability of success less than 10%? We have seen the NCI has had success to the point the cancer is just gone. If this happens in 50% of people, how many people would say “no I am not taking the chance”.
If the TCR trials are successful (even discounted) 1.2B for a MC is incredibly low.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 1     Views: 373
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...